Baseline Characteristics of Atopic Dermatitis (AD) and AD Treatments in a Cohort of Adult AD Patients Initiating Dupilumab in a Real-World Registry (PROSE). J of Skin 2020, 4 (6), s106. https://doi.org/10.25251/skin.4.supp.106.